NBC: FDA panel recommends the first shot to prevent RSV in infants by vaccinating pregnant mothers

The FDA voted to approve Pfizer’s recent RSV (Respiratory Syncytial Virus) vaccine that would protect against neonates by vaccinating their mothers while pregnant. GSK has also recently approved an RSV vaccine (but for older adults). Pfizer states the shot should be administered from 24 to 36 weeks into pregnancy. The FDA’s independent advisory committee voted both in favor for its efficacy and safety. Click here to learn more about Pfizer’s new vaccine.